Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil in Neuromyelitis Optica Spectrum Disorders
NCT02809079Phase 4Unknown
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of mycophenolate mofetil in Neuromyelitis Optica Spectrum Disorder (NMOSD), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Beyond the preview
Go deeper on NCT02809079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02809079.